Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents2. RESPIRATORY DISEASES
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents4. CARDIOVASCULAR DISEASES
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
close this folder12. TUBERCULOSIS AND LEPROSY
close this folder12.1 Tuberculosis
View the document12.1.1 Control of Tuberculosis
View the document12.1.2 Case Management
close this folder12.1.3 Treatment Categories
View the document12.1.3.1 Treatment Guidelines Catagory I
View the document12.1.3.2 Treatment guidelines Category II
View the document12.1.4 New Cases Other Than Smear Positive (PT)
View the document12.1.5 Chronic Cases
Open this folder and view contents12.2 Leprosy
Open this folder and view contents12.3 Treatment of Leprosy
View the document12.4 Prevention of Disabilities and rehabilitation
Open this folder and view contents12.5 Signs and Treatment of Severe Reversal Reaction (RR)
View the document12.6 Responsibilities
View the document12.7 How to Look After Ulcers
View the document12.8 Surveillance of Patients After Release from MDT
View the document12.9 Referral Criteria of Leprosy Patients
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 
12.1.3.2 Treatment guidelines Category II

These guidelines are given according to the National TB and Leprosy programme (NTLP) which are:

Standard regimen:

Streptomycin: give 1 g (IM)
every 24 hours for 8 weeks (for those weighing 50 kg or more and aged 40 years or less)

 

OR

 

give 750 mg every 24 hours for 8 weeks for those weighing less than 50 kg and aged 40 years or less.

Children:

Streptomycin: give 15 mg/kg body weight IM every 24 hours for 8 weeks.

For smear negative pulmonary and extra pulmonary tuberculosis, use the standard regimen. If streptomycin cannot be given (e.g. because of severe side effects), substitute

Ethambutol: 25 mg/kg body weight every 24 hours for 8 weeks.


NOTE

• If Ethambutol is to be given for more than 8 weeks reduce to 15 mg/kg body weight.
• Ethambutol should not be given to children.

Children see following table.

Table: Standard regimen for children

Pre-treatment weight

Number of (Thiazina tablets of 100 mg Isoniazid and 50 mg Thiacetazone) in one dose only

Number of (Thiazina tablets of 300 mg Isoniazid and 150 mg Thiacetazone) in one dose daily

Streptomycin (g) in one dose daily

< 10 kg

1/2

1/2

0.25

11-20 kg

1

1

0.50

21-30 kg

2

1

0.75

31-50 kg

3

1

0.75

> 51 kg

3

1

1.00

For newly diagnosed (previously untreated) smear positive patients use the short-course regimen as follows:

Table: Short-course regimen: dosages for adults

Daily during week 1-8

Daily during weeks 9-32

S

HR

z

TH

Pre-treatment weight

Streptomycin intramuscular injection

Isoniazid 100 mg Rifampicin 150 mg (combined tablets)

Pyrazinamide 0.5 tablets

Isoniazid 300 mg and Thiacetazone 150 mg OR Isoniazid 100 mg and Thiacetazone 150 mg

> 50 kg

1 gm

4

4

1 or 3

31-49 kg

0.75 gm

3

3

1 or 3

<30 kg

0.75 gm

2

2

1 or 2

Dosages in children:

Streptomycin: give 15 mg/kg body weight (not more than 1 g) every 24 hours.

Rifampicin: give 10 mg/kg body weight (not more than 600 mg) every 24 hours.

Pyrazinamide: give 30 mg/kg body weight (not more than 2 g) every 24 hours.

Thiazina: see table above.


NOTE • Streptomycin will be replaced by Ethambutol step wise in the country (starting 1992). In case of side effects with Thiazina, Ethambutol plus Isoniazid must be used.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French